Lykke Bjerglund Graff

Lykke Bjerglund Graff has a diverse work experience in the medical field spanning over three decades. Lykke Bjerglund is currently working at Zealand Pharma as a Senior Medical Director, where they have been since 2021. Prior to joining Zealand Pharma, they worked at LEO Pharma as the Vice President Global Safety from 2018 to 2021. From 2012 to 2018, they held various positions at LEO Pharma, including Head of Global Pharmacovigilance and Head of Section, Medical Science Dermatology, International Medical Department. Before their time at LEO Pharma, Lykke worked at Novo Nordisk for several years, serving as an International Medical Director from 2006 to 2012. Lykke Bjerglund also worked as Director, Safety Operations and Product Safety Adviser during their tenure at Novo Nordisk. Lykke's career in the medical field began with a residency at a hospital from 1990 to 1999. Throughout their career, Lykke Bjerglund Graff has gained extensive knowledge and experience in medical leadership, safety operations, and pharmacovigilance.

Lykke Bjerglund Graff obtained a Doctor of Medicine (MD) degree in Medicine from Københavns Universitet in the period 1982-1990. Later, they pursued a Doctor of Philosophy (PhD) degree in Rheumatology at the same university, which was completed in 1999. Additionally, they earned a Diploma in Managing Medical Product Innovation (MMPI) from the Scandinavian International Management Institute during the years 2009-2010.